Technical Analysis for DARE - Dare Bioscience, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 0.31 | -0.94% | 0.00 |
Earnings due: May 9
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Flat |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Calm After Storm | Range Contraction | 0.00% | |
NR7 | Range Contraction | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Stochastic Buy Signal | Bullish | -0.94% | |
Calm After Storm | Range Contraction | -0.94% | |
Wide Bands | Range Expansion | -0.94% | |
Oversold Stochastic | Weakness | -0.94% |
Alert | Time |
---|---|
Possible NR7 | about 12 hours ago |
Possible Inside Day | about 12 hours ago |
60 Minute Opening Range Breakdown | about 15 hours ago |
Down 2 % | about 15 hours ago |
Up 3% | about 16 hours ago |
Free Daily (Stock) Chart Reading
- Earnings date: 05/09/2024
Dare Bioscience, Inc. Description
Dare Bioscience, Inc., formerly Cerulean Pharma Inc., is a healthcare company. The Company is focused on the development and commercialization of products in women’s reproductive health. Its lead product candidate is Ovaprene, a clinical stage, non-hormonal contraceptive ring. The Company is developing Ovaprene to provide protection over multiple weeks of use and require no intervention at the time of intercourse. Ovaprene has a custom intravaginal ring design, with a permeable mesh in the center of the ring that creates a partial barrier to sperm, and a mechanism to release locally acting spermiostatic agents through the ring. The combination of these two complementary approaches produces attractive contraceptive efficacy outcomes that are consistent with the effective barrier option, the diaphragm, and short-acting hormonal options, such as oral pill, patches and vaginal ring.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Drugs Birth Control Vagina Women's Health Diaphragm Hormonal Contraception Medroxyprogesterone Acetate
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 1.06 |
52 Week Low | 0.27 |
Average Volume | 659,515 |
200-Day Moving Average | 0.45 |
50-Day Moving Average | 0.43 |
20-Day Moving Average | 0.34 |
10-Day Moving Average | 0.31 |
Average True Range | 0.04 |
RSI (14) | 38.65 |
ADX | 20.45 |
+DI | 18.42 |
-DI | 21.70 |
Chandelier Exit (Long, 3 ATRs) | 0.40 |
Chandelier Exit (Short, 3 ATRs) | 0.39 |
Upper Bollinger Bands | 0.48 |
Lower Bollinger Band | 0.19 |
Percent B (%b) | 0.4 |
BandWidth | 86.68 |
MACD Line | -0.04 |
MACD Signal Line | -0.04 |
MACD Histogram | 0.0037 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.33 | ||||
Resistance 3 (R3) | 0.34 | 0.33 | 0.33 | ||
Resistance 2 (R2) | 0.33 | 0.32 | 0.33 | 0.33 | |
Resistance 1 (R1) | 0.32 | 0.32 | 0.31 | 0.32 | 0.33 |
Pivot Point | 0.31 | 0.31 | 0.31 | 0.31 | 0.31 |
Support 1 (S1) | 0.30 | 0.30 | 0.29 | 0.30 | 0.29 |
Support 2 (S2) | 0.29 | 0.30 | 0.29 | 0.29 | |
Support 3 (S3) | 0.28 | 0.29 | 0.28 | ||
Support 4 (S4) | 0.28 |